|
|
Other links at Articles > Neurology and Neurosurgery |
| 2. |
DIAS-2 Revisited: Development of Desmoteplase for Stroke to Continue
|
|
|
After startling results of the DIAS-2 trial showed no benefit of the novel thrombolytic desmoteplase over placebo for ischemic stroke, the researchers and the company have had a good look at the data and conclude further study of the drug is probably warranted. Medscape Medical News
|
|
|